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Abstract
Background: A high coverage of human papillomavirus (HPV) vaccination is required to achieve a clinically
significant reduction in disease burden. Countries implementing free-of-charge national vaccination program for
adolescent girls are still challenged by the sub-optimal uptake rate. Voluntary on-site school-based mass vaccination
programs have demonstrated high coverage. Here, we tested whether this could be an option for countries
without a government-supported vaccination program as in Hong Kong.
Method: A Home-School-Doctor model was evolved based on extensive literature review of various health
promotion models together with studies on HPV vaccination among adolescent girls. The outcome measure was
uptake of vaccination. Factors associated with the outcome were measured by validated surveys in which 4,631
students from 24 school territory wide participated. Chi-square test was used to analyze association between the
categorical variables and the outcome. Multivariate analysis was performed to identify independent variables
associated with the outcome with vaccine group as case and non-vaccine group as control.
Results: In multivariate analysis, parental perception of usefulness of the Home-School-Doctor model had a very
high odds ratio for uptake of HPV vaccination (OR 26.6, 95 % CI 16.4, 41.9). Paying a reasonable price was another
independent factor associated with increased uptake (OR 1.71, 95 % CI 1.39, 2.1 for those with parents willing to
pay US$125-250 for vaccination). For parents and adolescents who were not sure where to get vaccination, this
model was significantly associated with improved uptake rate (OR 1.66, 95 % CI 1.23, 2.23). Concerns with side
effects of vaccine (OR 0.70, 95 % CI 0.55, 0.88), allowing daughters to make their own decisions (OR 0.49, 95 % CI
0.38, 0.64) and not caring much about daughters’ social life (95 % CI 0.45, 0.92) were factors associated with a lower
uptake.
Discussion: The findings of this study have added knowledge on how a school-based vaccination program would
improve vaccine uptake rate even when the users need to pay. Our findings are consistent with other study that
the most acceptable way to achieve high uptake of HPV vaccine is to offer voluntary school-based vaccination.
Conclusion: A model of care incorporating the efforts and expertise of academics and health professionals working
closely with school can be applied to improve the uptake of vaccine among adolescent girls. Subsidized voluntary
school-based vaccination scheme can be an option.
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Background
Many large scale studies have demonstrated the efficacy
of human papillomavirus (HPV) vaccines [1, 2]. Achiev-
ing a clinically significant reduction in the incidence of
cervical cancer requires a high coverage of vaccination
[3–5]. The uptake rates still vary among countries with
national HPV vaccination programs for adolescents, ran-
ging from very high in UK and Australia of around 70 %
[6, 7],medium (39 %) in Florida [8], and very low (17 %)
in France [9]. ‘Strict’ school-linked mandate would be an
option to improve uptake and a high coverage had also
been achieved by voluntary on-site school-based mass
programs [10] with one study demonstrating with 70 %
coverage by year 8 and maximum vaccination coverage,
90 % by year 43 [11]. Parents were 2.5 to 4 times more
likely to utilize school-based programs for immunization
if their children received the last immunization at school
than those children received vaccination at another site
[12]. However school-based programs are not without
barriers and oppositions.
Although the initial uptake rate of HPV vaccination pro-
gram in school was 70 to 80 % in Australia for the first
dose, the completion rates ranged from 55 to 77 % for the
third dose [6]. In USA, the uptake rate among girls aged
13–17 was 25 % for the first dose, but only 6.9 % com-
pleted the third dose [13]. Publicly funded school-based
program is not panacea for high uptake as parents still
possess concerns over the vaccine [14]. Gamble et al. has
summarized literatures reporting factors influencing fa-
milial decision regarding HPV vaccination and concluded
that attitudes and recommendations of health care pro-
viders, and belief and attitudes of parents and adolescents
were the key factors [15]. Other influential factors
included interfacing with the health care system, peer
norms, institutional policies and interventions such as
mandate for school vaccination, and communication
between parents and adolescents on sexual issues [15].
Health beliefs, developmental maturity, self-efficacy and
relatedness to caregivers were found to be individual ado-
lescent factors for uptake of the first dose,and response to
the first dose, experience with health care system during
the first visit, cost incurred obtaining the first dose, and
evolving community belief about the vaccine and HPV
were factors associated with adherence with the comple-
tion of the vaccine series according to conceptual frame-
work by Katz et al. [16]. Bandura highlighted self-efficacy
playing a role in the adoption of health behaviours in
changing detrimental habits and maintaining the change
[17]. Studies on cost-effectiveness of HPV vaccination
should include willingness to pay to reflect whether the
perceived values of benefits of consumers would exceed
the retail prices of HPV vaccines [18].
Half of the cervical cancer cases globally are in Asia
and but there are not many large-scale vaccination
programs even among the well-developed parts of Asia,
such as Taiwan, Hong Kong, Japan and South Korea
[19]. Although those countries had high uptake rate for
conventional vaccine-preventable diseases such as polio-
virus or measles, uptake of HPV vaccine is very low [20].
In Hong Kong, studies by Choi et al. in 2008 and 2012
revealed that 2.4 % schools girls reported having re-
ceived HPV vaccine and mothers reported 9.1 % their
daughters been vaccinated respectively [21]. Only 7 %
girls reported having received HPV vaccine by Lee et al.
study in 2008 [22]. Lack of knowledge and information,
concerns with efficiency and safety of vaccine, and not
perceiving the risks of HPV infections were found to be
commons reasons for not receiving the vaccine accord-
ing to studies by Lee et al. and Li et al. in Hong Kong
[22, 23]. These three recent Hong Kong studies have dis-
cussed the importance of school setting to equip adoles-
cent girls with valid information concerning HPV
vaccine as well as delivery of vaccine in school setting to
facilitate the uptake rate [21–23].
Studies in Netherland and USA reported that receiving
information from physicians and other community influ-
encers was positively associated with HPV vaccine
uptake [24–26]. Similarly in Hong Kong, multivariate
analysis identified three independent significant factors,
perceived threat of cancer, school providing more infor-
mation on cancer prevention, and comments from rela-
tives and friends having received the vaccine, were
associated with initiation of vaccination [22]. HPV
vaccine is currently not covered under the Government
vaccination program in Hong Kong at the time of this
study. A Home-School-Doctor Model would facilitate
the initiation of HPV vaccine among adolescent girls by
tackling the socio-cultural barriers as well as the finan-
cial and health care barriers. The model was based on
the theory of leading models of health promotion as well
as results of recent local studies and systematic review
of overseas studies, in particular those conducted after
approval of HPV vaccine [21–23, 27–34]. Our aim of
study was to investigate whether availability of this
model in school setting is an independent factor for par-
ental decision to have their daughters being vaccinated.
The study also aimed to identify other factors to be con-
sidered by parents independently associated with vaccine
uptake of their daughters. The findings could add value
to refine school-based vaccination program and also
have an important impact to improve and sustain the
uptake rate of vaccine.
Methods
Ethical statement
The study was approved by the Survey and Behavioral
Research Ethics Committee of the Chinese University of
Hong Kong. All clinical investigations have been conducted
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according to the principles expressed in the Declaration of
Helsinki. All participants (parents or legal guardians) were
asked to sign written consent for participation for the sur-
vey and the program if they decided to join in.
Theoretical framework and survey instrument
Research hypotheses were generated on improvement of
HPV vaccine uptake based on literature review of
school-based HPV vaccine programs and the interfacing
with health care systems [10, 14, 15, 17, 27–31, 33–35],
and the conceptual framework for behavioral change
models including vaccine uptake behavior [17, 32]. Study
by van Keulen et al. on both daughters and mothers re-
ported the importance of socio-psychological variables
to the explained variance of HPV vaccination so future
strategies to improve uptake should address attitudes,
beliefs, subjective norms and habit strength [34]. The
followings summaries the research hypotheses:
1. Mothers with correct understanding of HPV
infection and causative link to cervical cancer and
perception of seriousness of HPV infection and
cervical cancer are more likely to have their
daughters vaccinated;
2. Readily available information covering wider
perspective of cervical cancer prevention including
side effects and efficacy of HPV vaccine would
improve uptake rate;
3. More discussion with family doctors would have
motivating effect on uptake of HPV vaccine for
adolescent girls;
4. Parents are willing to pay for vaccine if the cost is
reasonable as well as social norm for vaccination as
mode of prevention
Those research hypotheses led to evolution of the
Home-School-Doctor model (Fig. 1) which is an eco-
logical model of modification of health behaviours by
acting at different levels from macro-level to meso-level
and down to micro-level. At macro-level, the inputs
from academics and professionals with evidence based
practice would cultivate the socio-political environment
and culture for HPV vaccination as preventive strategy
for cervical cancer. This would also have impact on
media and community awareness. This model also ad-
dresses the economic environment through subsidized
scheme for vaccination through school setting. The
changes at macro-level would enhance the joint effort of
academic and medical professionals working through
school setting and their social network to cultivate a
positive social normamong the adolescent girls and their
family members towards HPV vaccination as preventive
strategy at meso-level in the context of their daily life.
This would have impact at micro-level on individual be-
liefs, attitudes, values and perception leading to behav-
ioural changes.
Study design and data source
Figure 2 summarizes the flow of the study, the program
in addressing the research hypotheses and process of
data collection for the outcomes. Purposeful sampling
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Fig. 1 Framework for Health Behavioural Modification at different levels
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forum on cervical cancer prevention in July 2011. Those
schools expressing interest to join the program during a
school health forum were contacted, and a total of 24
schools from different districts of Hong Kong agreed to
participate. The field study was carried out between
November 2011 and May 2012. Each student received an
education pack with concise information on preven-
tion of cervical cancer, instruction to log on to an
online education platform (http://www.youitv.com/
partner/hps/cervicalcancer/), questionnaire, and infor-
mation of vaccination program with an informed consent
form. Parents and students were free to make their deci-
sions on receiving vaccine.
Parents were invited to fill in a self-administered
questionnaire as measuring tool. The survey tool was
designed to measure the possible variables correlated
with uptake of HPV vaccine based on the research
hypotheses. The questionnaire also included a ques-
tion as a variable by asking the parents whether the
availability of the Home-School-Doctor model had a
strong impact on their decisions to have their daughters
vaccinated. The contents were refined by experts in public
health and infectious diseases then pilot tested for face
and content validation.
The model was introduced to all participating schools.




Convenience & time spent of parents
Lack of knowledge on potential seriousness
Negative attitude towards vaccine
Lack of information from health care providers 
Lack of specific recommendation from health professionals
Inconvenience for vaccine in terms of time and venue
Program
Major barrier partially removed by:
Free 1st dose at school
Support of education materials
Support of primary care providers 
Outcome behavior group 1 (Non-vaccination 
group)
DO NOT participate in vaccination.
Those who join research study completed the 
questionnaire and return to school.
Outcome behavior group 2
(vaccination group)
Complete the consent form and choose a doctor from the 
“participated doctor list” for vaccination and return to 
school and they are encouraged to choose their own family 
physicians.
Complete the questionnaire and return to school.
Participate & receive full course of vaccination.
Identify significant correlates for differences in outcome behaviour
Uptake of HPV vaccine
Advocate to schools
If schools express interest to join, education packs will be 
distributed to parents which include:
- Information about cervical cancer and HPV  
vaccination and consent forms
- Questionnaire for research study
- Information about logging in of Online education 
platform(http://www.youitv.com/partner/hps/cervica
lcancer/)
- Participated doctor list.
Fig. 2 Testing of Intervention
Lee et al. BMC Public Health  (2015) 15:935 Page 4 of 12
those students receiving vaccination were classified as
cases and those not having vaccination were control.
The outcome was measured by uptake of vaccination or
not. Odds ratios of the different variables were calcu-
lated by univariate and multi-variate analysis to distin-
guish the case and the control.
Sample size
Based on the study in 2009 [22], the uptake rate of
vaccination amongst female students was 7 %, the number
of subjects needed to determine the proportion of uptake
rate with precision set at 0.01 will be 2,604.
Ne1:962  p 1‐pð Þ=precision2
In order to determine the number of subjects needed
in each group analyzing the difference between the vac-
cinated group and non-vaccinated group, the sample size
for each group will be:
Ne8 P0 1‐P0ð Þ=precision2
If among the vaccinated group, 30 % expressed one
particular predicting variable for vaccination (e.g., con-
venience) as important factor versus only 10 % among
the non-vaccinated group, the P0 would then be 0.2. If
the estimated precision is 0.02, the sample size of 3,200
is needed.
Statistical analysis
Questionnaires were collected and descriptive data from
all variables in the questionnaire were computed as ei-
ther categorical or continuous variables. The proportion
of students in each vaccination outcome behaviour
group was tabulated. Chi-square test was used to analyze
association between the categorical variables and the
vaccination outcome behaviors. For those continuous
variables, they were computed as scores. Cases were
those subjects who had received the vaccination (out-
come behaviour group 1). Non-vaccinated subjects were
defined as control group (outcome behaviour group 2).
Multivariate analysis was performed to identify inde-
pendent variables associated with the cases, outcome
behavior group 2. All data analysis was performed using
SPSS version 14.0. P values of less than 0.05 were
considered statistically significant.
Results
A total of 4,631 students (response rate 61.4 %) returned
from 24 schools situated in different districts of Hong
Kong participated in the survey and from valid question-
naires 1,605 in vaccination group and 2,648 in non-
vaccination group (Fig. 3). The characteristics of the
study population with reference to the whole Hong
Kong population are shown in Tables 1 and 2.
Figure 3 shows the reasons why the parents refused HPV
vaccination for their daughters as well as reasons for not
sending them for vaccination. Uni-variate analysis revealed
that the impact of Home-School-Doctor model, willingness
to pay, self-perceived knowledge on HPV vaccination,
understanding the link between HPV and cervical cancer,
information from and discussion with doctors, information
from friends/relatives or media, and not sure where to get
vaccination were factors associated with a higher uptake of
HPV vaccine (Table 3). Conversely, uncertainty of effective-
ness, concerns of early sexual behaviors after HPV vaccin-
ation, worries over side-effects, concerns of effect on
reproduction and menstruation, daughters not yet started
sexual activity, misconception of cervical cancer, letting
daughters to make their own decisions, and never heard of
HPV were factors associated with a lower uptake of HPV
vaccine. In multi-variate analysis, the impact of Home-
School-Doctor model was found to be the strongest associ-
ation for uptake of HPV vaccination (OR 26.6.6, 95 %
CI16.44, 41.96) (Table 4). Paying a reasonable price was also
another independent factor associated with uptake rate,
with parents willing to pay between HK$1,000 to 2,000
(US$125 to 250) having 1.71odds (95 % CI 1.39, 2.1) for up-
take of vaccine (Table 4). If parents and adolescents were
not sure where to get vaccination, the availability of this
model became an important factor for them to take up the
vaccine (OR 1.66, 95 % CI 1.23, 2.23) (Table 4). Concerns
with side effects of the vaccine, allowing daughters to make
their own decisions and not caring much on daughters’ so-
cial life were all significant independent factors associated
with a lower uptake of the vaccine (Table 4).
Discussion
The findings of this study have added knowledge on
how a school-based vaccination program would improve
vaccine uptake rate even when the users need to pay.
The study has identified independent factors associated
with higher or lower HPV vaccine uptake based on
multi-variate analysis. The ‘Home-School-Doctor’ model
had very strong impact on parents’ decision for their
daughter to opt for HPV vaccine with a very high odds
ratio (OR 26.6). Families willing to pay HK$1,000
(US$125) or more for a full course of vaccination were
also more likely to take up the vaccine. The availability
of the model increased parents’ likelihood to consider
vaccination if they were uncertain of possible venues for
vaccination. Worries over side effects were significant
independent factors associated with low uptake as well
as those parents allowing their daughters to make deci-
sion and not caring too much about their social life.
A systematic review published in 2012 identified fac-
tor such as coverage by health insurance, more health
care utilization particularly for preventive care, having
health care providers as source of information, positive
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attitude towards the vaccine and higher vaccine related
knowledge associated with HPV vaccine uptake among
teenage girls [24]. The systematic review also noted
considerably higher uptake rate in settings with a
school-based program. [6, 14, 17, 27, 36–38]. Our findings
are consistent with study by Skinner and Copper Robins
that the most acceptable way to achieve high uptake of
HPV vaccine is to offer voluntary school-based vaccin-
ation [10]. Skinner and Cooper Robins also addressed
voluntary on site-school-based mass vaccination as one of
the evidence-based approaches to increase vaccine uptake
among adolescents apart from strict mandate for vaccin-
ation [10]. Strict mandates have been debated with con-
troversies in USA as genital wart is exclusively sexual
transmitted so infected individuals do not pose an imme-
diate risk to others in school setting [39, 40].
The systematic review also highlighted the important
role of primary care providers in providing HPV-related
information and assisting girls to initiate and/or complete
the vaccine series. If both school setting and primary care
setting become reliable source of information for parents
and teenage girls, this would have significant impact on
the beliefs, attitudes and intention regarding HPV vaccin-
ation. Hong Kong study in 2009 reported that school pro-
viding information on cervical cancer prevention had
significantly motivated their consideration for HPV vac-
cination [22]. Study among Japanese mothers highlighted
the importance of physicians actively addressing the safety
concerns and the necessity for the vaccine at particular
age to achieve high uptake even in publically funded HPV
vaccine program [41]. Our Home-School-Doctor model
introduced the vaccine to parents via school setting
Reasons reported
A Worries over side effect of vaccine
B Too expensive
C Not sure where to go for vaccination
D Unknown efficacy of HPV vaccine
E Too early for daughter to vaccinate
F Difficult to discuss with daughter as related to sex
G Menstruation not yet stable
H Might affect reproduction
I Daughters have not started sexual activity
J Allow my daughter to decide
K Concerns of early sexual behaviour after HPV vaccination
A B C D E F G H I J K
Non-vaccinated (N=2648) 46.2% 41.8% 10.9% 42.3% 22.4% 8.3% 17.6% 13.4% 12.2% 19.6% 14.2%












Fig. 3 Reasons not refusing HPV vaccination in the past
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through academic institutions in partnership with physi-
cians in the local catchment area. The support of medical
professional organization in mobilizing district network of
doctors not only conveyed a strong message of endorse-
ment to the public, but also added confidence to both pri-
mary care providers and the recipients (parents and
teenage girls). Studies have shown a consistent finding
that primary care providers are less comfortable in vaccin-
ating younger versus older adolescents, and thus the
endorsement of vaccination by a professional organization
is of great importance [42]. The Home-School-Doctor
model has an additional endorsement from academic in-
stitution which could be important in the context where
Government’s official support is still lacking.
Paper by Tissot et al. addressed the needs of educating
paediatricians about the high prevalence of HPV among
all sexually active adolescents and universal recommen-
dation for the vaccine [42]. That study revealed the need
to enhance access to vaccination by providing HPV vac-
cines in alternative settings, addressing specific educa-
tional needs related to HPV and HPV vaccines, and
providing pediatricians with guidance as to how to
address the specific concerns that parents might have
about a vaccine for sexually transmitted disease. School
can therefore be an alternative setting. It is often difficult
to identify the educational needs for both consumers
and health care providers as they are from diverse back-
ground, especially the consumers. One would try to have
fact sheets with credible information provided by aca-
demic institution delivered via school setting matching
the educational needs of students and parents. Studies
have also shown the effectiveness of school-based health
promotion programs in changing health behaviors
including sexual behaviors [43], and improvement of
health literacy [44]. The online education video incorpo-
rated in our model not only allowed parents and stu-
dents to explore at their time of convenience, it also
enhanced their confidence with messages from doctors
in tackling the common myths regarding the vaccine
and prevention of cervical cancer. Both printed and on-
line materials could act as supplementary information
for schools in developing comprehensive school health
education on reproductive health and disease preven-
tion. A study by Garland et al. reported the high cover-
age rate of HPV vaccine in Australia after commencing
the school-based government vaccination program since
2007 [45]. The study also highlighted the challenge
around the public perceptions of the appropriateness
and safety of vaccinating large numbers of children in
school setting. The traditional separation of the roles of
health and education sectors regarding immunization
poses further challenges as students might not be well
informed, or the relevant information might not be read-
ily accessible to them. Parents and students might not
have the opportunity to ask further questions. This
Home-School-Doctor model has tried to resolve some of
these challenges by professional inputs and endorsement
from doctors and also academic institutions. It would
help those parents initially uncertain where to go for
vaccination as reflected by higher vaccine uptake of their
daughters (Table 3).
Parents expressing their wishes to let daughters to
make their own decisions or not caring much about the
Table 2 Age of respondents and schools distribution
Age of respondents In primary schools In secondary schools
Age 30 or below 16 (2.4 %) 192 (5.0 %)
Age 31–40 267 (40.0 %) 890 (23.0 %)
Age 41 or above 385 (57.6 %) 2785 (72.0 %)
Primary & secondary schools
distributionb (by district)
Schools in HK Schools joined HPV
program
HK South 87 (7 %)a 2 (8 %)
HK East 61 (5 %)a 2 (8 %)
Kowloon City 107 (8 %)a 3 (13 %)
Wong Tai Sin 68 (5 %)a 1 (4 %)
Kwun Tong 83 (6 %)a 2 (8 %)
TuenMun 89 (7 %)a 4 (17 %)
Yuen Long 112 (9 %)a 2 (8 %)
Tai Po 54 (4 %)a 1 (4 %)
Sai Kung 68 (5 %)a 3 (13 %)
Kwai Tsing 108 (8 %)a 4 (17 %)
aSchool Lists (By District) (2013/14) (Last Updated: Oct 2013), Education and
Manpower Bureau, HKSAR (Hong
Kong) http://applications.edb.gov.hk/schoolsearch/schoolsearch.aspx?langno=1
bPrimary education 6 years, secondary education 7 years
Table 1 Characteristics of the study participantscompared to





Total numbers of schools 24 1018
Number of primary schools 12 528a
Number of secondary schools 12 490a




Number of secondary schools
students
3944 418,787a
Level of education of respondents
Primary school level or belowc 11.0 % 29.4 %b
Secondary school levelc 72.6 % 54.8 %b
Tertiary or above 16.4 % 15.8 %b
aEducation and Manpower Bureau, HKSAR (Hong Kong)http://www.edb.
gov.hk/tc/about-edb/publications-stat/figures/index.html (Last revision date:
09 July 2013)
bCensus and Statistics Department, HKSAR (Hong Kong), 2011
cPrimary education 6 years, secondary education 7 years
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Table 3 The association between parents’ response to
questionnaire and uptake of HPV vaccine by school girls using
univariate analysis
OR 95 % CI P
Availability of the current
Home-School-Doctor model
No 1 Reference
Yes 36.09 (24.68, 52.79) <0.001
Amount (HK$) willing to pay
for a full course
<1,000 1 Reference
1,001–2,000 2.02 (1.75, 2.33) <0.001
>2,001 1.70 (1.42, 2.03) <0.001
Parents self-perceived




Somewhat sufficient 1.40 (1.21, 1.63) <0.001
Sufficient & very sufficient 1.59 (1.35, 1.88) <0.001
Not sure where to go for
vaccination
No 1 Reference
Some importance as a
factor to consider
1.30 (1.11, 1.53) 0.002
Important/very important 1.44 (1.19, 1.74) <0.001
I have frequent chat with daughter
No 1 Reference
Yes 1.34 (1.11, 1.61) 0.002
Consider protection sustainability
in choosing HPV vaccine
No 1 Reference
Yes 1.31 (1.16, 1.49) <0.001
Consider protection to cervical
cancer inchoosing HPV vaccine
No 1 Reference
Yes 1.26 (1.11, 1.44) <0.001
Vaccine can produce antibodies
against HPV
No 1 Reference
Yes 1.21 (1.07, 1.37) 0.002
Cervical cancer is caused by HPV
No 1 Reference 0.001
Yes 1.26 (1.10, 1.45)
I would discuss about prevention
of cervical cancer with doctor
Definitelyb not/No/Maybe not 1 Reference
Yes/Maybe 1.11 (0.96, 1.28) 0.16
Yes/Definitely yes 1.21 (1.03, 1.42) 0.02
Table 3 The association between parents’ response to
questionnaire and uptake of HPV vaccine by school girls using
univariate analysis (Continued)
Heard about HPV vaccine from
TV/magazine
No 1 Reference
Yes 1.44 (1.21, 1.71) <0.001
Heard about HPV vaccine from
school
No 1 Reference
Yes 1.20 (1.02, 1.42) 0.03
Never heard about HPV vaccine
No 1 Reference
Yes 0.55 (0.36, 0.83) 0.005
Worries over side effect of vaccine
No 1 Reference
Some importance as a factor to
consider
1.07 (0.90, 1.29) 0.45
Important/Very important 0.62 (0.52, 0.74) <0.001
Menstruation not yet stable
No 1 Reference
Some importance as a factor to
consider
0.93 (0.80, 1.08) 0.35
Important/Very important 0.62 (0.51, 0.74) <0.001
Allow my daughter to decide
No 1 Reference
Some importance as a factor to
consider
0.57 (0.49, 0.68) <0.001
Important/Very important 0.40 (0.33, 0.48) <0.001
Unknown efficacy of HPV vaccine
No 1 Reference
Some importance as a factor to
consider
1.10 (0.92, 1.31) 0.29
Important/Very important 0.73 (0.62, 0.86) <0.001
Too early for daughter to vaccinate
No 1 Reference
Some importance as a factor to
consider
0.82 (0.70, 0.96) 0.012
Important/Very important 0.80 (0.68, 0.94) 0.006
Difficult to discuss with daughter
as related to sex
No 1 Reference
Some importance as a factor
to consider
0.81 (0.68, 0.98) 0.027
Important/Very important 0.85 (0.68, 1.07) 0.16
Might affect reproduction
No 1 Reference
Some importance as a factor
to consider
0.74 (0.62, 0.87) <0.001
Important/Very important 0.77 (0.64, 0.93) 0.008
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social life of their daughters were found to be less likely
to join the program. Women with no sex experience
usually reported not being at risk as the main reason for
not wanting the vaccination [46]. The prevalence of early
sexual experience among adolescent girls in Hong Kong
is not high [47]. If parents left the decision entirely to
their daughters, they would perceive themselves not
being at risk and not taking up the vaccination during
early adolescence for better protection.
This model has also provided educational opportun-
ities for health care providers. Seminars were organized
for them with the latest update on HPV vaccine covering
safety, duration of immunity, contraindications and
description of HPV-related diseases. The seminars also
provided practical tips in raising sensitive issues with
teenage girls. A recent study from Hong Kong has
revealed a low level of knowledge on HPV infection
among primary care physicians, and their prescription of
HPV vaccine was hindered by the perceived parental
concerns, and they relied passively on Government rec-
ommendations [48]. The opportunity for doctors to give
health talk to schools in this program would help the
doctors to gain better understanding on the needs and
concerns of parents and young girls, thus further provid-
ing reassurance to them. Information is also available in
CD format for those doctors who could not attend the
seminars. Fulfilling the education needs of primary care
providers is important as this will indirectly improve
communication to the consumers. Health professionals
remain central in influencing parents’ decision and
parental intention to have their daughters vaccinated
approximates the uptake rate [49].
Cost has been identified as an important factor in many
studies [35], therefore the subsidized price would help to
boost up the vaccination uptake among parents. US study
by Brown et al. revealed mean willingness to pay was
US$560 on average for 80 % cervical cancer prevention
for duration of 10 years even without added protection
against genital warts [178. The GDP per capita in Hong
Table 3 The association between parents’ response to
questionnaire and uptake of HPV vaccine by school girls using
univariate analysis (Continued)
Daughters have not started
sexual activity
No 1 Reference
Some importance as a factor
to consider
0.64 (0.53, 0.78) <0.001
Important/Very important 0.65 (0.53, 0.80) <0.001
Concerns of early sexual behaviour
after HPV vaccination
No 1 Reference
Some importance as a factor
to consider
0.73 (0.61, 0.88) 0.001
Important/Very important 0.62 (0.51, 0.76) <0.001
I do not care about daughter’s
social life
No 1 Reference
Yes 0.66 (0.51, 0.86) 0.0021
Cervical cancer is inherited
No 1 Reference
Yes 0.72 (0.60, 0.86) <0.001
Cervical cancer happens only on those with
multiple sex partners
No 1 Reference
Yes 0.80 (0.66, 0.98) 0.033
Table 4 Association between parents’ response to
questionnaire and uptake of HPV vaccine by school girls using
multi-variate analysis
OR 95 % CI P
Availability of Current Home-School
-Doctor Model
No 1 Reference
Yes 26.6 (16.44, 41.96) <0.001
Amount (HK$) willing to pay for a
full course
<1,000 1 Reference
1,001-2,000 1.71 (1.39, 2.10) <0.001
>2,000 1.39 (1.05, 1.84) 0.023
Not sure where to go for vaccination
No 1 Reference
Some importance as a factor to
consider
1.45 (1.14, 1.84) 0.003
Important/ Very important 1.66 (1.23, 2.23) 0.001
Allow my daughter to decide
No 1 Reference
Some importance as a factor to
consider
0.59 (0.46, 0.74) <0.001
Important and very important 0.45 (0.34, 0.58) <0.001
Do not care about daughter’s
social life
No 1 Reference
Yes 0.62 (0.41, 0.94) 0.026
Consider protection sustainability
in choosing HPV vaccine
No 1 Reference
Yes 1.21 (1.00, 1.46) 0.048
Parents self-perceived knowledge
on HPV vaccine
Very insufficient, insufficient &
somewhat insufficient
1 Reference
Somewhat sufficient 1.20 (0.96, 1.50) 0.11
Sufficient & very sufficient 1.38 (1.05, 1.80) 0.020
Lee et al. BMC Public Health  (2015) 15:935 Page 9 of 12
Kong is comparable to USA (US$36,667 and US$49,922,
respectively, according to International Monetary Union,
2012) so one would target those families willing to pay
US$250 for the full course (Table 4). The current market
price of three doses of HPV vaccine in Hong Kong is
around US$400. Whilst the Hong Kong Government does
not provide a free-of-charge HPV vaccination program, it
could consider a subsidized scheme in school setting
similar to our model.
Apart from cost, school-based vaccination is a complex
initiative with many logistic factors needs to be consid-
ered. These include dissemination, collection and record-
ing of consent forms, management of adolescent anxiety
on site, as well as education of teachers, parents and
students about vaccination [45]. Our model managed to
address some of those complex logistic factors smoothly,
which was the key to success. While the setting of schools
and colleges would offer special opportunities for vaccine
delivery, school attendance is variable particularly in less
well developed countries [50]. This current model would
lead us to consider adopting the concept of healthy setting
approach to promote health in the context of their living
environment as school is only one example of setting.
One would consider non-traditional, non-institutional
settings such as social venues for youth relevant to
particular culture to ensure that the settings approach
would respond to societal changes and addresses
inequalities [51].
There is strong evidence that engagement of adolescents
would lead to higher compliance with medical advice [45].
Adolescents who had the energy and willpower to take
care of themselves, complied with health regimens with a
6.69 fold likelihood compared to adolescents who did not
have energy and willpower [45]. Our study showed that
those parents wanting to leave decision to their daughter
or not wanting to deal with their social life were less likely
to opt for HPV vaccination for their daughters. More ac-
tive engagement and direct involvement with adolescents
is another strategy for improvement of HPV vaccination
among the young age group. In fact, many of the partici-
pating schools continued to arrange HPV vaccination
using this model.
There are several limitations to this study. The partici-
pation of schools, students and parents was voluntary,
so there could be a volunteer bias. The self-selection ra-
ther than random selection could affect the representa-
tiveness of our study population. Nevertheless, if a lot of
randomly selected schools declined and not co-operated
with the protocol, this would forfeit the aims of the
study. Our study population consisted of schools from
different parts of the territory with higher proportion
from districts which were not in metropolitan areas, and
a substantial proportion came from lower socio-
economic class. We also noticed that the education level
of parents in this study was higher comparable to whole
Hong Kong population.
We only used the completion of second dose at pri-
mary care clinic as a measurement of uptake rate. As
the families needed to pay for second dose and they
chose their own primary care clinics, they were highly
unlikely to default the third dose. The research team
used SMS message to remind them for the second and
third dose, and their primary providers also had re-
minder mechanism. Although they all received the first
dose free and needed to pay for the second dose, and yet
over 80 % of the students attended for second dose at
their chosen primary care clinics. Once the primary care
providers have established rapport with their patients,
their compliance to preventive health services in primary
care setting is very high [51, 52, 53].
Conclusion
A model of care incorporating the efforts and expertise
of academics and health professionals working closely
with school setting can have great impact on uptake of
HPV vaccine among adolescent girls, making other bar-
riers relatively insignificant. This model could address
the unmet educational and health needs of parents, stu-
dents and school educators. Some of those participating
schools had self-initiated similar vaccination program
the year after, and there are still on-going enquiries from
those schools as well as schools not participated previ-
ously. Voluntary school-based vaccination at subsidized
rate would be a model to promulgate and sustain the
HPV vaccination program if a free national program is
not feasible. Continuous research is needed to refine the
delivery model in meeting the complex needs of all
stakeholders.
What is ready known to this topic?
The uptake of HPV vaccine among adolescents varies
among countries with universal coverage. Inadequate
knowledge of cervical cancer prevention, concerns of vac-
cine efficacy and side effects, lack of recommendations
from health professionals have been found as major bar-
riers. The voluntary school based vaccination programs
have shown to improve uptake rate.
What this study adds?
This is the first study conducted in a country without
national vaccination program to test the efficacy of a
non-Government-led school-based program. The Home-
School-Doctor model addressed the main barriers
including the financial concerns. It was found that adoption
of the model is substantially more likely to be associated
with HPV vaccine uptake, and this bears strong implica-
tions for healthcare professionals and school stakeholders
Lee et al. BMC Public Health  (2015) 15:935 Page 10 of 12
to design and implement this model in school settings
via an organized, concerted effort to improve vaccine
uptake rates.
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